BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 14687153)

  • 1. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
    Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
    Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
    Mearin F; Balboa A; Badía X; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):165-72. PubMed ID: 12560761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is Unspecified Functional Bowel Disorder? A Commonly Seen, Rarely Recognized, and Poorly Understood Diagnosis.
    Ballou S; Rangan V; Eidelberg A; Proctor S; McHenry N; Nee J; Iturrino J; Lembo A; Singh P
    Am J Gastroenterol; 2023 Aug; 118(8):1402-1409. PubMed ID: 37053553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran.
    Roshandel D; Rezailashkajani M; Shafaee S; Zali MR
    Int J Colorectal Dis; 2006 Dec; 21(8):814-25. PubMed ID: 16565819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.
    Vandvik PO; Aabakken L; Farup PG
    Scand J Gastroenterol; 2004 May; 39(5):448-53. PubMed ID: 15180182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What impact do Rome IV criteria have on patients with IBS in China?
    Wang B; Zhao W; Zhao C; Jin H; Zhang L; Chen Q; Wang B
    Scand J Gastroenterol; 2019 Dec; 54(12):1433-1440. PubMed ID: 31829752
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey.
    Kosako M; Akiho H; Miwa H; Kanazawa M; Fukudo S
    Biopsychosoc Med; 2018; 12():18. PubMed ID: 30534195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional bowel disorders in Iranian population using Rome III criteria.
    Sorouri M; Pourhoseingholi MA; Vahedi M; Safaee A; Moghimi-Dehkordi B; Pourhoseingholi A; Habibi M; Zali MR
    Saudi J Gastroenterol; 2010; 16(3):154-60. PubMed ID: 20616409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.
    Mearin F; Baró E; Roset M; Badía X; Zárate N; Pérez I
    Am J Gastroenterol; 2004 Jan; 99(1):113-21. PubMed ID: 14687152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.
    Mearin F; Badía X; Balboa A; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Scand J Gastroenterol; 2001 Nov; 36(11):1155-61. PubMed ID: 11686214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    Ono M; Kato M; Miyamoto S; Tsuda M; Mizushima T; Ono S; Nakagawa M; Mabe K; Nakagawa S; Muto S; Shimizu Y; Kudo M; Katsuki S; Meguro T; Sakamoto N
    J Gastroenterol; 2018 Aug; 53(8):916-923. PubMed ID: 29305648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.
    Krogsgaard LR; Engsbro AL; Bytzer P
    Scand J Gastroenterol; 2013 May; 48(5):523-9. PubMed ID: 23506174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.